Stereotactic body radiation therapy as initial treatment for head and neck cancer
Stereotactic Body Radiation Therapy (SBRT) emerges as a pioneering approach for primary treatment in head and neck squamous cell cancer (HNSCC) management. This study explores SBRT's efficacy, safety, and outcomes as the initial therapeutic modality for HNSCC. SBRT's precision targeting an...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Oral Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Stereotactic Body Radiation Therapy (SBRT) emerges as a pioneering approach for primary treatment in head and neck squamous cell cancer (HNSCC) management. This study explores SBRT's efficacy, safety, and outcomes as the initial therapeutic modality for HNSCC. SBRT's precision targeting and high doses enable localized tumor control while sparing adjacent healthy tissues, mitigating treatment-related morbidities. This doctrine delves into SBRT's evolving role, detailing its impact on tumor response rates, survival outcomes, and quality of life indicators. Furthermore, it elucidates the patient selection criteria, treatment protocols, and technological advancements shaping SBRT's application in HNSCC. Comprehensive evaluation of SBRT's feasibility and effectiveness underscores its potential as a paradigm-shifting approach in the primary management of HNSCC, offering promising prospects for improved therapeutic outcomes and patient well-being. |
|---|---|
| ISSN: | 2772-9060 |